TABLE 5: % Zero survival

Percentage (%) of zero survival cases (persons)
Country average (population) Country average (country) England Scotland Northern Ireland Wales
All invasive xnmsc 1.2% 1.0% 1.2% 0.5% 0.5% 1.9%
All xnmsc 0-24 0.4% 0.3% 0.4% 0.0% 0.0% 0.7%
All xnmsc 25-59 0.4% 0.2% 0.4% 0.2% 0.0% 0.2%
All xnmsc 60-79 0.8% 0.7% 0.8% 0.4% 0.4% 1.1%
All xnmsc 80+ 3.1% 2.8% 3.1% 1.1% 1.3% 5.6%
All registrations 0.8% 0.7% 0.8% 0.3% 0.3% 1.3%
Haematology 1.3% 1.3% 1.3% 0.4% 0.6% 2.7%
Head and Neck 0.4% 0.2% 0.4% 0.1% 0.0% 0.1%
Lower GI 1.1% 0.8% 1.1% 0.4% 0.2% 1.6%
Upper GI 1.3% 1.0% 1.4% 0.2% 0.0% 2.4%
HPB 2.4% 1.9% 2.5% 0.8% 0.8% 3.4%
Trachea, Bronchus & Lung 1.8% 1.3% 1.9% 0.5% 0.7% 2.2%
Melanoma of skin 0.0% 0.0% 0.1% 0.0% 0.0% 0.0%
Breast 0.4% 0.4% 0.4% 0.1% 0.1% 0.9%
Cervix 0.6% 0.4% 0.6% 0.3% 0.0% 0.6%
Other Female Genitals 1.1% 1.0% 1.1% 0.8% 0.9% 1.4%
Prostate 0.5% 0.5% 0.5% 0.1% 0.2% 1.0%
Kidney 1.5% 1.0% 1.6% 0.3% 0.0% 2.2%
Bladder 1.3% 1.2% 1.3% 0.4% 0.4% 2.8%
Brain and CNS 1.1% 0.8% 1.2% 0.4% 0.0% 1.7%
Thyroid & other endocrine glands 0.8% 0.6% 0.8% 1.1% 0.0% 0.6%
CUP 7.1% 6.1% 7.4% 3.0% 3.7% 10.1%
Other invasive cancer 2.4% 3.0% 2.2% 2.8% 2.7% 4.4%
Breast in situ 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cervix in situ 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Other tumours 0.9% 0.8% 1.0% 0.2% 0.1% 1.8%